NeuroPace Inc (NPCE): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$11.34M
Year ended 2025-12-31
-$11.61M
Trailing 12 months to 2026-06-30
2020-12-31: -$21.67M2021-12-31: -$24.96M2022-12-31: -$37.47M2023-12-31: -$19.87M2024-12-31: -$18.25M2025-12-31: -$11.34M-$11.34M
2020-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$11.34Mn/m2026-03-03, From 2025-01-01
2024-12-31-$18.25Mn/m2026-03-03, From 2024-01-01
2023-12-31-$19.87Mn/m2025-03-04, From 2023-01-01
2022-12-31-$37.47Mn/m2024-03-05, From 2022-01-01
2021-12-31-$24.96Mn/m2023-03-02, From 2021-01-01
2020-12-31-$21.67Mn/a2022-03-10, From 2020-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
NeuroPace Inc (NPCE)2025-12-31-$11.34Mn/m
Beta Bionics, Inc. (BBNX)2025-12-31-$56.22Mn/m
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30-$116.59Mn/m
Pulmonx Corp (LUNG)2025-12-31-$32.83Mn/m
Anika Therapeutics, Inc. (ANIK)2025-12-31$4.36Mn/m
Orasure Technologies Inc (OSUR)2025-12-31-$53.22Mn/m
Delcath Systems, Inc. (DCTH)2025-12-31$20.97Mn/m
Iradimed Corp (IRMD)2025-12-31$17.18M-2.5%
TELA Bio, Inc. (TELA)2025-12-31-$28.67Mn/m

Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗